Mimedx Group Inc (MDXG)

12:19 PM

Healing wounds with insights: How MiMedx powers innovation in healthcare with Strategy solutions - Strategy

12:19 PM

Mar 12, 2026

ETF Watch: Whats the beta of MiMedx Group Inc stockQuarterly Profit Report & Fast Gaining Stock Reports - baoquankhu1.vn

Mar 12, 2026

Mar 12, 2026

Earnings Risk: Will MiMedx Group Inc announce a stock split2026 Highlights & Reliable Breakout Stock Forecasts - baoquankhu1.vn

Mar 12, 2026

Mar 07, 2026

How MiMedx Group Inc. stock performs in rising dollar environment2025 Growth vs Value & Accurate Intraday Trade Tips - Naître et grandir

Mar 07, 2026

Mar 06, 2026

Market Pulse: Can MiMedx Group Inc be recession proof2025 Momentum Check & Daily Volume Surge Signals - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy - MSN

Mar 06, 2026

Mar 06, 2026

Trigran Investments Inc. Sells 689,430 Shares of MiMedx Group, Inc $MDXG - MarketBeat

Mar 06, 2026

Mar 06, 2026

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields - Sahm

Mar 06, 2026

Mar 05, 2026

Aug Technicals: Is MiMedx Group Inc a speculative investmentJuly 2025 Trends & Low Drawdown Investment Ideas - baoquankhu1.vn

Mar 05, 2026

Mar 05, 2026

MiMedx (MDXG) Launches New AMNIOFIX Thyroid Shields - GuruFocus

Mar 05, 2026

Mar 05, 2026

MiMedx Group (NASDAQ:MDXG) Sets New 1-Year LowWhat's Next? - MarketBeat

Mar 05, 2026

Mar 03, 2026

The Rosen Law Firm Files Securities Fraud Class Action Against MiMedx Group, Inc.MDXG - AOL.com

Mar 03, 2026

Mar 03, 2026

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential - DirectorsTalk Interviews

Mar 03, 2026

Mar 03, 2026

InvestingPro Fair Value flagged MiMedx as overvalued before 47% drop By Investing.com - Investing.com Canada

Mar 03, 2026

Mar 02, 2026

Global Placenta Extract Market Size, Growth, Trends & Forecast to 2033 telaGen, BIOON, MiMedx Group - openPR.com

Mar 02, 2026

Mar 02, 2026

Analysts Issue Forecasts for MiMedx Group Q1 Earnings - MarketBeat

Mar 02, 2026

Mar 01, 2026

MiMedx Group (MDXG) Delivers Record Full Year Revenue - Finviz

Mar 01, 2026

Feb 28, 2026

MiMedx Group (NASDAQ:MDXG) Downgraded by Wall Street Zen to Buy - MarketBeat

Feb 28, 2026

Feb 27, 2026

Q2 EPS Estimates for MiMedx Group Lowered by Analyst - MarketBeat

Feb 27, 2026

Feb 27, 2026

MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year LowWhat's Next? - MarketBeat

Feb 27, 2026

Feb 26, 2026

MiMedx Group (NASDAQ:MDXG) Stock Price Down 8.8%Here's What Happened - MarketBeat

Feb 26, 2026

Feb 26, 2026

MiMedx Group Q4 Earnings Call Highlights - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Transcript : MiMedx Group, Inc., Q4 2025 Earnings Call, Feb 25, 2026 - marketscreener.com

Feb 26, 2026

Feb 25, 2026

Earnings call transcript: MiMedx Q4 2025 sees robust growth, EPS beats forecast - Investing.com UK

Feb 25, 2026

Feb 25, 2026

MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results - The Globe and Mail

Feb 25, 2026

Feb 25, 2026

MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates - Nasdaq

Feb 25, 2026

Feb 25, 2026

MiMedx Group (NASDAQ:MDXG) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat

Feb 25, 2026

Feb 25, 2026

MIMEDX Group Inc (NASDAQ:MDXG) Stock Dips Despite Strong Earnings Beat - ChartMill

Feb 25, 2026

Feb 25, 2026

MiMedx (MDXG) Q4 2025 Earnings Call Transcript - AOL.com

Feb 25, 2026

Feb 25, 2026

MiMedx: Q4 Earnings Snapshot - marketscreener.com

Feb 25, 2026

Feb 25, 2026

Earnings Flash (MDXG) MiMedx Group, Inc. Posts Q4 Adjusted EPS $0.14 per Share, vs. FactSet Est of $0.09 - marketscreener.com

Feb 25, 2026

Feb 25, 2026

Earnings Flash (MDXG) MiMedx Group, Inc. Reports Q4 Revenue $118.1M, vs. FactSet Est of $106.8M - marketscreener.com

Feb 25, 2026

Feb 25, 2026

MiMedx (MDXG) details wound-care expansion, new products and Medicare shifts - Stock Titan

Feb 25, 2026

Feb 24, 2026

MiMedx Group, Inc. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com

Feb 24, 2026

Feb 24, 2026

What to Expect from MiMedx Group's Earnings - Benzinga

Feb 24, 2026

Feb 24, 2026

MiMedx Group Inc (MDXG) Q4 2025 Earnings Report Preview: What to Look For - GuruFocus

Feb 24, 2026

Feb 24, 2026

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 24, 2026

Feb 23, 2026

MiMedx Group (MDXG): Citizens Initiates Coverage with Market Out - GuruFocus

Feb 23, 2026

Feb 23, 2026

MiMedx Group (NASDAQ:MDXG) Now Covered by Citizens Jmp - MarketBeat

Feb 23, 2026

Feb 23, 2026

MiMedx Group, Inc (NASDAQ:MDXG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 23, 2026

Feb 23, 2026

Beyond The Numbers: 4 Analysts Discuss MiMedx Group Stock - Benzinga

Feb 23, 2026

Feb 23, 2026

This MiMedx Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Feb 23, 2026

Feb 23, 2026

Citizens Initiates Coverage of MiMedx Group (MDXG) with Market Outperform Recommendation - Nasdaq

Feb 23, 2026

Feb 23, 2026

Citizens initiates MiMedx stock with outperform on reimbursement outlook By Investing.com - Investing.com Canada

Feb 23, 2026

Feb 23, 2026

Citizens initiates MiMedx stock with outperform on reimbursement outlook - Investing.com

Feb 23, 2026

Feb 23, 2026

How The MiMedx (MDXG) Investment Story Is Resetting Around CMS And Analyst Revisions - Yahoo Finance

Feb 23, 2026

Feb 21, 2026

What catalysts could drive MiMedx Group Inc. stock higherJuly 2025 Market Mood & Breakout Confirmation Trade Signals - mfd.ru

Feb 21, 2026

Feb 20, 2026

MSN Money - MSN

Feb 20, 2026

Feb 20, 2026

Will MiMedx Group Inc. stock benefit from AI adoption2025 Dividend Review & AI Forecasted Entry and Exit Points - mfd.ru

Feb 20, 2026

Feb 20, 2026

Stem Cell and Regenerative Therapy Markets, 2022-2025 & - GlobeNewswire

Feb 20, 2026

Feb 20, 2026

Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading CompaniesGilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More - Yahoo Finance

Feb 20, 2026